Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Complement system is not activated in primary biliary cirrhosis.
[benign recurrent intrahepatic cholestasis]
There
is
controversial
evidence
suggesting
that
the
classical
pathway
of
complement
system
is
chronically
activated
in
primary
biliary
cirrhosis
(
PBC
)
and
that
complement
activation
may
be
important
in
development
of
bile
duct
injury
.
We
have
reevaluated
this
issue
by
measuring
by
-products
of
complement
activation
such
as
C
4
a
,
C
3
a
,
Bb
,
and
terminal
complement
complexes
(
SC
5
b
-
9
)
in
plasma
of
44
PBC
patients
with
sensitive
methods
not
previously
used
to
detect
complement
activation
in
this
disease
.
Age-matched
healthy
women
and
patients
with
chronic
hepatitis
of
different
etiology
were
studied
as
controls
.
We
found
that
PBC
patients
have
normal
C
4
a
concentrations
.
This
finding
argues
strongly
against
chronic
classical
pathway
activation
.
Although
a
minor
increase
of
C
3
a
levels
was
observed
in
a
minority
of
PBC
patients
,
the
C
3
a
/
C
3
ratio
,
an
index
used
to
evaluate
the
extent
of
native
protein
conversion
,
was
remarkably
similar
in
all
groups
.
Potentially
lytic
terminal
complement
complexes
were
not
increased
.
PBC
patients
had
normal
Bb
plasma
levels
,
indicating
that
the
alternative
pathway
is
also
not
activated
.
C
3
concentration
was
higher
in
PBC
patients
than
in
healthy
subjects
and
in
chronic
hepatitis
patients
,
particularly
in
the
early
stages
of
the
disease
.
C
3
and
C
4
concentrations
became
lower
in
PBC
and
chronic
hepatitis
with
the
progression
of
the
disease
.
The
increase
of
C
3
concentration
in
PBC
does
not
reflect
liver
inflammation
,
since
serum
levels
of
C-
reactive
protein
are
normal
.
We
found
high
serum
C
3
levels
in
patients
with
rare
chronic
cholestatic
syndromes
without
superimposed
infections
and
observed
that
serum
C
3
levels
paralleled
those
of
bilirubin
in
a
patient
with
benign
recurrent
intrahepatic
cholestasis
.
In
conclusion
,
our
data
indicate
that
complement
is
not
activated
in
PBC
and
that
the
increase
of
serum
C
3
levels
is
related
to
cholestasis
.
Diseases
Validation
Diseases presenting
"chronic hepatitis with the progression of the disease"
symptom
benign recurrent intrahepatic cholestasis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom